Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Behzad Etemad, Ph.D.

Concepts

This page shows the publications Behzad Etemad has written about Viral Envelope Proteins.
Connection Strength

0.802
  1. Early infection HIV-1 envelope V1-V2 genotypes do not enhance binding or replication in cells expressing high levels of a4ß7 integrin. J Acquir Immune Defic Syndr. 2013 Nov 01; 64(3):249-53.
    View in: PubMed
    Score: 0.395
  2. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes. Am J Trop Med Hyg. 2008 Sep; 79(3):353-63.
    View in: PubMed
    Score: 0.276
  3. Human immunodeficiency virus type 1 V1-to-V5 envelope variants from the chronic phase of infection use CCR5 and fuse more efficiently than those from early after infection. J Virol. 2009 Oct; 83(19):9694-708.
    View in: PubMed
    Score: 0.073
  4. Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes. Am J Trop Med Hyg. 2006 Feb; 74(2):266-77.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.